Navigation Links
Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2008 Financial Results
Date:5/6/2008

SCOTTSDALE, Ariz., May 6 /PRNewswire-FirstCall/ -- Matrixx Initiatives, Inc. (Nasdaq: MTXX), an over-the-counter healthcare company that develops and markets products that provide consumers with "Better Ways to Get Better(R)," announced today that financial results for the fiscal fourth quarter and year ended March 31, 2008 will be released after the market closes on Monday, May 12, 2008. An earnings conference call will be held the following morning on Tuesday, May 13, 2008 at 11:00 AM ET.

To access the teleconference, please call (877) 863-5191 (domestic) or (706) 643-6826 (international), access number 46849571. To listen to the teleconference via the Internet, go to http://www.matrixxinc.com and click on the fourth quarter fiscal 2008 teleconference icon.

A replay of the call will be available at (800) 642-1687 (domestic) or (706) 645-9291 (international), access number 46849571 for 3 days following the call, and the web cast will be archived on the company's website, http://www.matrixxinc.com, for 30 days.

About Matrixx Initiatives, Inc.

Matrixx Initiatives, Inc. is engaged in the development, manufacture and marketing of over-the-counter healthcare products that utilize innovative drug delivery systems. Zicam, LLC, its wholly-owned subsidiary, produces, markets and sells Zicam(R) and Nasal Comfort(TM) products in the cough and cold category. The Company's flagship product, Zicam Cold Remedy nasal gel, is a patented, homeopathic remedy that has been clinically proven to reduce the duration and severity of the common cold. In studies published in the October 2000 issue of ENT -- Ear, Nose and Throat Journal, and separately in the January 2003 issue of QJM: An International Journal of Medicine, the Zicam Cold Remedy product was shown to reduce the duration of the common cold. The Company also manufactures and markets a full line of Zicam brand pharmaceuticals, including Zicam Cold Remedy Chewables(TM); Zicam Cold Remedy Oral Mist(TM); Zicam Cold Remedy RapidMelts(TM); Zicam Allergy Relief; Zicam Cold Remedy Swabs(TM); Zicam Extreme Congestion Relief; Zicam Sinus Relief; as well as Zicam Cough products and Zicam Multi-Symptom relief items. For more information regarding Matrixx products, go to http://www.Zicam.com. To find out more about Matrixx Initiatives, Inc. (Nasdaq: MTXX), visit our website at http://www.matrixxinc.com. For additional information, contact William Hemelt, Chief Financial Officer, 602-385-8888, or Bill Barba, Treasurer, at 602-385-8881. Matrixx is located at 8515 E. Anderson Dr., Scottsdale, Arizona 85255.


'/>"/>
SOURCE Matrixx Initiatives, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Rising Medical Solutions Partners With myMatrixx to Deliver Integrated Pharmacy Management Solutions
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
3. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
4. Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2008 Financial Results
5. Matrixx Initiatives, Inc. Updates 2007/2008 Cold Season Trends and Fiscal 2008 Sales and Earnings Outlook
6. Matrixx Initiatives, Inc. to Present at the William Blair & Company Small-Cap Growth Stock Conference
7. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
8. New Medicare and Medicaid Data Released: Featuring Up-To-Date Enrollment Trends, State Initiatives, Regional Market Share and Prescription Drug Benefits
9. Vermillion to Host Live Roundtable Discussion With Lead Investigator of its Peripheral Artery Disease Diagnostic Test Program
10. Congress Debates Policy Discussion to Be Streamed Live on NextGenWeb.org
11. Inforum Presents Panel Discussion on The Future of the U.S. Health Care System: What It Will Cost in Dollars and Quality of Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... York, New York (PRWEB) , ... January 24, 2017 , ... ... for Brazilian butt lifts is on the rise. According to the American Society ... augmentations since 2000. On average, these procedures are performed every 30 minutes of every ...
(Date:1/24/2017)... PA (PRWEB) , ... January 24, 2017 , ... ... showcase its newest technology offering, Processing Assurance Control Equipment (PACE), at the International ... 2, 2017. , PeroxyChem’s booth will highlight the new technology that is used ...
(Date:1/24/2017)... ... January 24, 2017 , ... Twelve startups have been ... 2017 Cupid's Cup Entrepreneurship Competition. Chaired by Under Armour Founder and CEO Kevin ... will showcase their businesses on February 6, 2017, at Under Armour’s global headquarters ...
(Date:1/24/2017)... ... January 24, 2017 , ... Bellus Medical, a leader in medical aesthetics, today ... his new role Dr. Dobke will provide physician oversight for in-house clinical studies and ... of Plastic Surgery and Associate Professor of Surgery at UC San Diego Health and ...
(Date:1/24/2017)... ... January 24, 2017 , ... Inspiration, ... , Well-meaning studies such as the Fordham Institute’s High Stakes for High ... students, such as including gifted or high-achieving students as a subgroup and reporting ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... GERMANTOWN, Md. , and GAITHERSBURG, Md. ... XON ), a leader in the engineering and ... health of the planet, today announced that it has entered ... (NASDAQ: GNVC ), a clinical-stage company and pioneer ... Intrexon intends to integrate and expand upon GenVec,s expertise ...
(Date:1/24/2017)... 2017   QR Pharma , Inc., a ... therapies for the treatment of Alzheimer,s, Parkinson,s and ... four world-class key opinion leaders to its Scientific ... Pharma,s previous roster of impressive advisors in order ... the development of the breakthrough mechanism of action ...
(Date:1/24/2017)... Jan 24, 2017 Research and Markets has ... - Sensor, Actuator - Forecast to 2025" report to their ... Global ... 17.6% over the next decade to reach approximately $76.24 million by ... is witnessing include growing count of labs using optogentic techniques for ...
Breaking Medicine Technology: